+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pill, IUD, Diaphragm, Subdermal Implant, Condom, Vaginal Ring, Sponge, Injectable, Patch), And Segment Forecasts, 2018 - 2025

  • ID: 4700900
  • Report
  • Region: United States
  • 70 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Agile Therapeutics
  • Church & Dwight Co., Inc.
  • Cooper Companies, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co. Inc.
  • Pfizer, Inc.
  • MORE
The U.S. contraceptive market size is expected to reach at USD 11.6 billion by 2025 expanding at a CAGR of 5.3% over the forecast period. Increasing awareness about long-acting reversible contraceptive is expected to augment the product demand, thereby driving the market over the next few years. Availability of various contraceptive options for both men and women and growing awareness about the use of contraceptive among teens in the region are also likely to fuel the U.S. contraceptive market.

Furthermore, recent mergers & acquisitions along with commercialization of newer drugs and devices are likely to propel the market growth over the forecast period. For instance, in July 2015, a new diaphragm, Caya, launched in U.S. after 50 years of gap. The device is 94% effective when used perfectly. Among different contraceptive product types, oral contraceptive pills accounted for the largest share of the regional market in 2017 mainly due to its effectiveness, easy availability, and low costs.

Further key findings from the study suggest:

Condom segment accounted for the second-largest share of the market. This can be attributed to its ability to provide protection against Sexually Transmitted Diseases (STDs)

Intrauterine Device (IUD) segment accounted for the significant share in 2017 and is expected to register a CAGR of 6.7% during the forecast period

Subdermal implant segment is expected to observe the fastest growth during the forecast period due to its 100% affectivity, easy insertion and removal mechanism, and ability to prevent pregnancy for 3 to 5 years

Some of the key companies in the U.S. contraceptive market are Mayer Laboratories, Inc.; Teva Pharmaceutical Industries Ltd.; Bayer AG, Reckitt Benckiser Plc; Pfizer, Inc.; Cooper Surgical, Inc.; Church & Dwight Co., Inc.; and Merck & Co.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agile Therapeutics
  • Church & Dwight Co., Inc.
  • Cooper Companies, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co. Inc.
  • Pfizer, Inc.
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.2 Market restraint analysis
3.2 Penetration & Growth Prospects Mapping
3.3 U.S. Contraceptive Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 U.S. Contraceptive Market Competitive Landscape: Market Position Analysis (Based on Product Portfolio, Country Presence, and Recent Updates)

Chapter 4 U.S. Contraceptive Market : Product Estimates & Trend Analysis
4.1 U.S. Contraceptive Market: Product Analysis
4.2 Pill
4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.3 Condom
4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.3.2. Male Condom
4.3.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.3.3. Female Condom
4.3.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.4 Diaphragm
4.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.5 Sponge
4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.6 Vaginal Ring
4.6.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.7 Subdermal Implant
4.7.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.8 IUD
4.8.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.8.2. Hormonal IUD
4.8.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.8.3. Nonhormonal IUD
4.8.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
4.9 Patch
4.9.1. Market estimates and forecast, 2014 - 2025 (USD Million)
4.10 InjecTable
4.10.1. Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 5 Competitive Landscape
5.1 Strategy framework
5.2 Company Profiles
5.2.1 Church & Dwight Co., Inc.
5.2.1.1 Company overview
5.2.1.2 Financial performance
5.2.1.3 Product benchmarking
5.2.1.4 Strategic initiatives
5.2.2 Reckitt
5.2.2.1 Company overview
5.2.2.2 Financial performance
5.2.2.3 Product benchmarking
5.2.2.4 Strategic initiatives
5.2.3 Merck & Co. Inc.
5.2.3.1 Company overview
5.2.3.2 Financial performance
5.2.3.3 Product benchmarking
5.2.3.4 Strategic initiatives
5.2.4 Pfizer, Inc.
5.2.4.1 Company overview
5.2.4.2 Financial performance
5.2.4.3 Product benchmarking
5.2.4.4 Strategic initiatives
5.2.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.
5.2.5.1 . Company overview
5.2.5.2 Financial performance
5.2.5.3 Product benchmarking
5.2.5.4 Strategic initiatives
5.2.6 Cooper Companies, Inc.
5.2.6.1 Company overview
5.2.6.2 Financial performance
5.2.6.3 Product benchmarking
5.2.6.4 Strategic initiatives
5.2.7 Mayer Laboratories, Inc.
5.2.7.1 Company overview
5.2.7.2 Financial performance
5.2.7.3 Product benchmarking
5.2.7.4 Strategic initiatives
5.2.8 Agile Therapeutics
5.2.8.1 Company overview
5.2.8.2 Financial performance
5.2.8.3 Product benchmarking
5.2.8.4 Strategic initiatives


Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Church & Dwight Co., Inc.
  • Reckitt
  • Merck & Co. Inc.
  • Pfizer, Inc.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • Cooper Companies, Inc.
  • Mayer Laboratories, Inc.
  • Agile Therapeutics
Note: Product cover images may vary from those shown
Adroll
adroll